| Sign In to gain access to subscriptions and/or personal tools. |
DOI: 10.1177/1534735406295311 © 2006 SAGE Publications Case Report of a Pituitary Macroadenoma Treated With ArtemetherDepartment of Bioengineering, Box 355061, University of Washington, Seattle, WA 98195. narendra{at}u.washington.edu
Primary Health Center, Jaroda, Muzafarnagar (U.P.), India. Introduction: This report describes the case of a male patient with pituitary macroadenoma treated with the artemisinin analog artemether. Patient and Methods: A 75 year-old male patient presented with vision, hearing, and locomotion-related problems. Artemether was administered orally to the patient over a period of 12 months. Results: Although the tumor remained consistent in size, CT scan shows a reduction in its density, and clinically, the related symptoms and signs resolved significantly as therapy progressed. Discussion: Overall, the artemether treatment was beneficial in improving the patient's quality of life. Artemether and other artemisinin analogs offer promise for cancer therapy.
Key Words: artemether artemisinin pituitary gland microadenoma cancer apoptosis
|
